Non-small cell lung cancer (NSCLC)

You have access
Long-term Responders to Nanoparticle Albumin-bound Paclitaxel Following Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer
KOKI NAKASHIMA, YUKIHIRO UMEDA, YOSHIKI DEMURA, KOJI YAMAOKA, TOMOAKI SONODA, TOSHIHIKO TADA, YUKO WASEDA and TAMOTSU ISHIZUKA

Anticancer Research November 2024, 44 (11) 5105-5111; DOI: https://doi.org/10.21873/anticanres.17335
You have access
Smoking History Predicts High Presence of TILs and Efficacy of PD-1 Blockade in PD-L1 Expression-negative Non-small Cell Lung Cancer Patients
YUKIKO SHIMODA, TATSUYA YOSHIDA, MASAYUKI SHIRASAWA, TAKAAKI MIZUNO, HITOMI JO, YUJI MATSUMOTO, YUKI SHINNO, YUSUKE OKUMA, YASUSHI GOTO, HIDEHITO HORINOUCHI, NOBORU YAMAMOTO, YASUSHI YATABE, YUICHIRO OHE and NORIKO MOTOI

Anticancer Research November 2021, 41 (11) 5739-5747; DOI: https://doi.org/10.21873/anticanres.15390
You have access
Impact of COX2 Inhibitor for Regulation of PD-L1 Expression in Non-small Cell Lung Cancer
KATSUHIKO SHIMIZU, RIKI OKITA, SHINSUKE SAISHO, AI MAEDA, YUJI NOJIMA and MASAO NAKATA

Anticancer Research August 2018, 38 (8) 4637-4644; DOI: https://doi.org/10.21873/anticanres.12768
You have access
In Vitro and In Vivo Antitumor Effects of Pyrimethamine on Non-small Cell Lung Cancers
MENG-XIAN LIN, SHENG-HAO LIN, CHI-CHEN LIN, CHING-CHIEH YANG and SHEAU-YUN YUAN

Anticancer Research June 2018, 38 (6) 3435-3445; DOI: https://doi.org/10.21873/anticanres.12612
You have access
Postoperative Management of Multiple Primary Cancers Associated with Non-small Cell Lung Cancer
FUMIHIRO SHOJI, KOJI YAMAZAKI, NAOKO MIURA, MASAKAZU KATSURA, YUKA OKU, SADANORI TAKEO and YOSHIHIKO MAEHARA

Anticancer Research June 2018, 38 (6) 3773-3778; DOI: https://doi.org/10.21873/anticanres.12660
You have access
Prognostic Significance of Serum CEA for Non-small Cell Lung Cancer Patients Receiving Stereotactic Body Radiotherapy
TAKASHI SHINTANI, YUKINORI MATSUO, YUSUKE IIZUKA, TAKAMASA MITSUYOSHI, TAKASHI MIZOWAKI and MASAHIRO HIRAOKA

Anticancer Research September 2017, 37 (9) 5161-5167;
You have access
Docetaxel in the Treatment of Non-small Cell Lung Cancer (NSCLC) – An Observational Study Focusing on Symptom Improvement
ANDREAS PIRCHER, INES KRISTIN WASLE, MICHAEL MIAN, GABRIELE GAMERITH, ERNST ULSPERGER, MICHAEL STUDNICKA, ANDREA MOHN-STAUDNER, WOLFGANG HILBE and MICHAEL FIEGL

Anticancer Research September 2013, 33 (9) 3831-3836;
You have access
Prognostic Value of Preoperative Metabolic Tumor Volumes on PET-CT in Predicting Disease-free Survival of Patients with Stage I Non-small Cell Lung Cancer
YIN LIN, WAN-YU LIN, CHIA-HUNG KAO, KUO-YANG YEN, SHANG-WEN CHEN and JUN-JUN YEH

Anticancer Research November 2012, 32 (11) 5087-5091;

Main menu

User menu

Search

Non-small cell lung cancer (NSCLC)